Association between Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatic Cancer: Current Concepts and Future Challenges.

Bader, Husam; Yamin, Saif; Alshahwan, Hamzeh; Farraj, Husam; Maghnam, Joud; Abu Omar, Yazan

Bader, Husam; Yamin, Saif; Alshahwan, Hamzeh; Farraj, Husam; Maghnam, Joud; Abu Omar, Yazan.

Afiliação

Bader H; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Yamin S; School of Medicine, University of Jordan, Amman 11942, Jordan.
Alshahwan H; School of Medicine, University of Jordan, Amman 11942, Jordan.
Farraj H; Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87106, USA.
Maghnam J; School of Medicine, Al-Balqa' Applied University, Al-Salt 19117, Jordan.
Abu Omar Y; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

J Clin Med ; 13(11)2024 May 27.

Article em En | MEDLINE | ID: mdl-38892843

Palavras-chave

FIB-4 index; hepatic cancer; hepatocellular carcinoma; liver fibrosis; liver fibrosis score; metabolic-dysfunction-associated steatotic liver disease; non-alcoholic fatty liver disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google